Perception of Advanced Rehabilitation Technologies Among Post-Stroke Patients and Rehabilitation Staff

NCT ID: NCT06986421

Last Updated: 2025-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-08

Study Completion Date

2026-07-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational study aims to assess the perception of advanced rehabilitation technologies among three key groups involved in stroke recovery: post-stroke patients, physicians specialized in Physical and Rehabilitation Medicine, and allied health professionals. The study is conducted at HCL - Renée Sabran Hospital , specifically within the Kermes 2 department. Participants are selected using a non-probability sampling method, based on predefined inclusion and exclusion criteria. Data will be collected using a structured, author-developed questionnaire designed to evaluate attitudes, perceived usefulness, ease of use, and intention to adopt technologies such as exoskeletons, social robots, wearable interactive devices, and biofeedback systems. The questionnaire is applied at a single time point after obtaining informed consent. This research responds to the growing integration of technology in neurorehabilitation and seeks to identify potential barriers or facilitators to its adoption in clinical practice.

The hypothesis is that there is a significant difference in perception and acceptance of advanced rehabilitation technologies between the three groups, influenced by their respective roles, experience, and level of exposure to such technologies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Post-stroke patients

This group includes patients with a confirmed diagnosis of stroke, hospitalized or followed at HCL - Renée Sabran Hospital (Kermes 2 department), regardless of whether they have previously used advanced rehabilitation technologies.

completion of a structured questionnaire

Intervention Type OTHER

completion of a structured questionnaire

Physicians in Physical and Rehabilitation Medicine

This group consists of physicians specialized in Physical and Rehabilitation Medicine, actively involved in the treatment and rehabilitation of post-stroke patients. Recruited from HCL - Renée Sabran Hospital and affiliated professional networks

completion of a structured questionnaire

Intervention Type OTHER

completion of a structured questionnaire

Allied health professionals

This group includes allied health professionals involved in stroke rehabilitation, such as physiotherapists, occupational therapists, psychologists, speech therapists, neuropsychologists, and psychomotor therapists. All participants are affiliated with the HCL - Renée Sabran Hospital or collaborating institutions

completion of a structured questionnaire

Intervention Type OTHER

completion of a structured questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

completion of a structured questionnaire

completion of a structured questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients: Patients diagnosed with stroke, whether or not they have benefited from advanced rehabilitation technologies.
* Physicians: Physicians specialized in Physical and Rehabilitation Medicine who manage patients with stroke.
* Allied health professionals: Physiotherapists, psychologists, occupational therapists, speech therapists, neuropsychologists, and psychomotor therapists involved in the rehabilitation of post-stroke patients.

Exclusion Criteria

* Refusal to participate in the study.
* Patients who do not wish to benefit from advanced rehabilitation technology.
* Healthcare professionals with no experience using advanced rehabilitation technologies.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David PLANTIER, DR

Role: PRINCIPAL_INVESTIGATOR

HCL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

HCL - Renée Sabran Hospital

Hyères, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

David PLANTIER, Dr

Role: CONTACT

+33494381720

Victor-Andrei Stan, Dr

Role: CONTACT

+33772151051

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Victor Andrei Stan, Dr

Role: primary

+33772151051

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A01110-49

Identifier Type: OTHER

Identifier Source: secondary_id

69HCL25_0378

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.